Karen Tait has quit as head of external communications at drugs
Her decision follows the completion of the merger between Pharmacia &
Upjohn and Monsanto, which created Pharmacia in March last year.
Tait, previously communications manager at Monsanto's pharmaceutical
division, Searle, has decided to take voluntary redundancy rather than
carry on with the merged company.
She said: 'I saw the option of voluntary redundancy as a good time to
leave and pursue other things. I'm considering a number of
Tait had been with Searle for 17 years. She started working in sales and
marketing before switching to PR.
She added that the relocation from High Wycombe, Searle's base, to
Milton Keynes, Pharmacia's base, was another factor in her
Pharmacia is currently looking for a replacement for Tait, who leaves
She currently reports to Roy Sutherwood, Pharmacia director of public
The head of external communications role is part of a nine-strong
communications team and deals with media relations and managing external
Pharmacia is best known for producing the Nicorette anti-smoking range
Other brands in the portfolio include Zyvox, which is used in the
treatment of bacterium MRSA. It also produces cancer drugs Camptosar for
the treatment of colorectal cancer and Ellence used in the treatment of
breast cancer at an early stage
Pharmacia Corporation has 60,000 employees in 60 countries.